TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $47.45M2014: $187.22M2015: $212.38M2016: $178.49M2017: $162.61M2018: $99.47M2019: $408.93M2020: $841.65M2021: $679.33M2022: $480.85M2023: $629.60M2024: $448.53M2025: $258.34M$258.34M
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$258.34M-42.4%
2024$448.53M-28.8%
2023$629.60M+30.9%
2022$480.85M-29.2%
2021$679.33M-19.3%
2020$841.65M+105.8%
2019$408.93M+311.1%
2018$99.47M-38.8%
2017$162.61M-8.9%
2016$178.49M-16.0%
2015$212.38M+13.4%
2014$187.22M+294.6%
2013$47.45M—